Related Experiment Video

Updated: Jun 22, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.7K

Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variants

Martha Nance1, Oliver Phillips2, Thomas F Tropea3

  • 1Neurology, University of Minnesota, Struthers Parkinson's Center, 6701 Country Club Drive, Golden Valley, MN, United States.

Parkinsonism & Related Disorders
|July 4, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Disease modificationGenetic counselingGenetic testingGeneticsNeuroethicsNeurogeneticsParkinson diseasePredictive testing

More Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.0K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.0K

Related Experiment Videos

Last Updated: Jun 22, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.7K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.0K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.0K

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.3K
Genetic Screens02:46

Genetic Screens

4.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.9K

Articles linked to this work by shared authors, journal, and citation graph.

A Self-Administered, Digitized Approach to Quantifying the Cardinal Motor Symptoms in Parkinson's Disease.

Sensors (Basel, Switzerland)·2026

Deep brain stimulation battery longevity: a cohort study comparing impact of anaesthesia modality and anatomic target.

BMJ neurology open·2026

PD GENEration: An International Parkinson's Disease Genetic Research Study.

medRxiv : the preprint server for health sciences·2026

Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative.

Annals of neurology·2026

Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative.

Annals of neurology·2026

Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers Initiative.

Annals of neurology·2026

Genetic context unmasks olfactory loss as a marker for dyskinesia risk via levodopa exposure trajectories in Parkinson's disease.

Parkinsonism & related disorders·2026

Factors associated with suicidal ideation in people with parkinsonism: findings from the PRIME-UK cross-sectional study.

Parkinsonism & related disorders·2026

Parkinson's disease cognitive rehabilitation of executive functioning (PD-CoRE): A community-based intervention study.

Parkinsonism & related disorders·2026

Consensus expert recommendations for management of urinary dysfunction in Parkinson disease.

Parkinsonism & related disorders·2026

The classificatory ambiguity of task-specific tremor.

Parkinsonism & related disorders·2026

FGF14 (GAA) repeat expansion-associated Ataxia (SCA27B): Expanding the clinical and diagnostic spectrum from the first genetically confirmed case in Argentina.

Parkinsonism & related disorders·2026

Are Urooncologists Onboard?

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

The State of the Art of Theranostics and Its Future.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

[Alzheimer's disease: scientific advances, diagnostic challenges and therapeutic perspectives].

Soins; la revue de reference infirmiere·2026

Photobiomodulation therapy and the regulation of excitation-inhibition balance in neurological and psychiatric disorders: Mechanistic and translational perspectives.

Neuroscience·2026

Threshold Price of Belantamab for Relapsed/Refractory Multiple Myeloma in China: A Cost-Effectiveness Analysis.

PharmacoEconomics - open·2026

MiR-590-3p Targets HMGB1 to Alleviate Endothelial Injury Induced by β2GPI/Anti-β2GPI Immune Complex.

International journal of immunogenetics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us